Epigenetic alterations in aging
- 1 August 2010
- journal article
- review article
- Published by American Physiological Society in Journal of Applied Physiology
- Vol. 109 (2), 586-597
- https://doi.org/10.1152/japplphysiol.00238.2010
Abstract
Aging is a multifaceted process characterized by genetic and epigenetic changes in the genome. The genetic component of aging received initially all of the attention. Telomere attrition and accumulation of mutations due to a progressive deficiency in the repair of DNA damage with age remain leading causes of genomic instability. However, epigenetic mechanisms have now emerged as key contributors to the alterations of genome structure and function that accompany aging. The three pillars of epigenetic regulation are DNA methylation, histone modifications, and noncoding RNA species. Alterations of these epigenetic mechanisms affect the vast majority of nuclear processes, including gene transcription and silencing, DNA replication and repair, cell cycle progression, and telomere and centromere structure and function. Here, we summarize the lines of evidence indicating that these epigenetic defects might represent a major factor in the pathophysiology of aging and aging-related diseases, especially cancer.Keywords
This publication has 125 references indexed in Scilit:
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- SIRT1 Redistribution on Chromatin Promotes Genomic Stability but Alters Gene Expression during AgingCell, 2008
- Murine microRNAs implicated in liver functions and aging processMechanisms of Ageing and Development, 2008
- Intra-individual Change Over Time in DNA Methylation With Familial ClusteringJAMA, 2008
- Chromatin Modifications and Their FunctionCell, 2007
- Chromatin Challenges during DNA Replication and RepairCell, 2007
- The Epigenomics of CancerCell, 2007
- Genomic DNA methylation: the mark and its mediatorsTrends in Biochemical Sciences, 2006
- Histone Demethylation Mediated by the Nuclear Amine Oxidase Homolog LSD1Cell, 2004
- Upregulation and Nuclear Recruitment of HDAC1 in Hormone Refractory Prostate CancerThe Prostate, 2004